RetinalGenix Technologies, Inc. delivered its S-1/A Registration Statement to the U.S. Securities and Exchange Commission on October 1, 2021. Up to 1,591,806 shares of common stock are being offered by this prospectus, all of which are being registered for sale for the accounts of the Selling Stockholders. The company will not receive any of the…
This content is viewable by members only. Visit MY ACCOUNT on the top menu to log in or to register for a 30 day free trial or purchase a subscription for UV Reporter 1 Year Single Membership or UV Reporter 1 Year Group Membership - $189 for first member and $25 for each additional member.
